CIK: 1291087 - Address: C/o Corbus Pharmaceuticals Holdings, Inc, 500 River Ridge Drive, Norwood, MA 02062
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret111213-9-1710-41-7
P%wins10010000100050
S%ret113-2-3-5-21-4-73-18
S%wins671001001006710089

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/16/18 16:09
11/14/18
CRBPCorbus Pharmaceuticals Holdings, Inc.DEHealthDrugPharmaceutical PreparationsTepper MarkMAOP,CSOM.d101.0001002,110D
11/26/14 10:10
11/25/14
CRBPCorbus Pharmaceuticals Holdings, Inc.DEHealthDrugPharmaceutical PreparationsTepper MarkMAOP,CSOP63.050202,101D-14-9213-9-1710-41
5/10/07 12:55
5/9/07
CYTRCytrx CorpDEHealthBioPrdBiological Products, (No DiagTepper MarkMAOVPM.d1812.411750D37919716946-10-441-3-7-11-16-14-76
5/10/07 12:55
5/9/07
CYTRCytrx CorpDEHealthBioPrdBiological Products, (No DiagTepper MarkMAOVPS.d-3234.301-75-1000D37919716946-10-441-3-7-11-16-14-76
5/4/07 16:46
5/2/07
CYTRCytrx CorpDEHealthBioPrdBiological Products, (No DiagTepper MarkMAOVPM.d1812.411750D36616222042-9-12-71-4-2-3-28-12-73
5/4/07 16:46
5/2/07
CYTRCytrx CorpDEHealthBioPrdBiological Products, (No DiagTepper MarkMAOVPS.d-3144.181-75-1000D36616222042-9-12-71-4-2-3-28-12-73
5/1/07 15:27
4/27/07
CYTRCytrx CorpDEHealthBioPrdBiological Products, (No DiagTepper MarkMAOVPM.d1812.412750D35914921562-11-19-8-910-1-2013-70
5/1/07 15:27
4/27/07
CYTRCytrx CorpDEHealthBioPrdBiological Products, (No DiagTepper MarkMAOVPS.d-3084.112-75-1000D35914921562-11-19-8-910-1-2013-70

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact